Felty Syndrome, a subtype of RA characterized by symptoms similar to LGL leukemia such as concomitant neutropenia and splenomegaly, demonstrates a STAT3 mutation rate of 43% (19). This evidence concerns the gene STAT3 and Felty syndrome.